Cargando…
The impact of lipid-lowering medications on coronary artery plaque characteristics
Atherosclerosis is the predominant cause of coronary artery disease. The last several decades have witnessed significant advances in lipid-lowering therapies, which comprise a central component of atherosclerotic cardiovascular disease prevention. In addition to cardiovascular risk reduction with dy...
Autores principales: | Pulipati, Vishnu Priya, Alenghat, Francis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627965/ https://www.ncbi.nlm.nih.gov/pubmed/34877559 http://dx.doi.org/10.1016/j.ajpc.2021.100294 |
Ejemplares similares
-
The association of sex-specific hormones with coronary artery plaque characteristics from Miami Heart (MiHeart) study
por: Kwapong, Yaa A., et al.
Publicado: (2023) -
Inhibition of macrophage proliferation dominates plaque regression in response to cholesterol lowering
por: Härdtner, Carmen, et al.
Publicado: (2020) -
Plaque Distribution Correlates With Morphology of Lenticulostriate Arteries in Single Subcortical Infarctions
por: Jiang, Shuai, et al.
Publicado: (2020) -
Magnetic Resonance Imaging of Plaque Morphology, Burden, and Distribution in Patients With Symptomatic Middle Cerebral Artery Stenosis
por: Dieleman, Nikki, et al.
Publicado: (2016) -
Metabolic and inflammatory risk reduction in response to lipid-lowering and lifestyle modification in the medically underserved individuals
por: Chu, Michael P., et al.
Publicado: (2021)